N-α-Fmoc-D-Arginine

N-α-Fmoc-D-Arginine is an Fmoc-protected D-arginine amino acid derivative featuring an Fmoc carbamate on the α-amino group and a stereodefined side chain bearing a guanidinium functionality. The molecule contains the amino acid backbone with a free carboxylic acid (or carboxylate under basic conditions) and a strongly basic, resonance-stabilized guanidine that can participate in hydrogen bonding and ionic interactions. The D configuration at the α-carbon provides stereochemical control for incorporation into peptide sequences and for generating diastereomerically defined analogs in structure-activity relationship studies. The Fmoc group supports standard base-labile protecting-group chemistry, enabling iterative peptide coupling while preserving the guanidinium side chain for selective downstream manipulation.

1. Peptide Synthesis

N-α-Fmoc-D-Arginine is used in peptide building workflows where orthogonal protection and iterative N-terminal deprotection are required for controlled chain assembly. The Fmoc carbamate masks the α-amino group for compatibility with common peptide coupling reagents, while the free carboxylic acid enables formation of amide bonds during peptide elongation. The D-arginine stereochemistry can be incorporated to generate epimeric peptide analogs that probe stereochemical requirements for binding, stability, and receptor recognition. The guanidinium side chain supports salt-bridge formation in growing sequences and can be retained for electrostatic character during synthesis, with subsequent side-chain modification possible when required for downstream studies.

2. Chemical Biology

N-α-Fmoc-D-Arginine is applied in chemical biology programs that require arginine-bearing peptide probes, cell-penetrating motifs, or receptor-binding scaffolds with defined stereochemistry. The guanidinium group provides a cationic interaction handle for biomolecular recognition and can be leveraged for conjugation strategies such as guanidinium-preserving labeling or controlled derivatization to tune charge density. The Fmoc-protected α-amino functionality supports incorporation into peptide conjugates using peptide coupling chemistry, enabling the preparation of stereochemically defined ligands for binding assays and mechanistic studies. The D configuration helps differentiate stereospecific binding modes and supports the construction of epimeric series for mapping structure-function relationships in protein and nucleic acid interaction contexts.

3. Bioconjugation Chemistry

N-α-Fmoc-D-Arginine is suitable for bioconjugation workflows where arginine-rich linkers or peptide handles are needed to connect biomolecules to dyes, affinity tags, or functional nanoparticles. The protected α-amino group allows controlled peptide assembly to generate a conjugation-ready intermediate with a defined N-terminus, while the guanidinium side chain can serve as a persistent charged moiety that influences solubility and interaction with biological targets. The carboxylic acid functionality participates in peptide bond formation to install the arginine residue at a specific position within a linker architecture. Downstream conjugate generation can proceed through peptide-derived handles, enabling construction of labeled biomolecule variants and stereodefined conjugation reagents for analytical and biochemical research.

4. Protected Amino Acid Intermediate

N-α-Fmoc-D-Arginine functions as a chiral protected amino acid intermediate for manufacturing and research-grade synthesis of D-arginine-containing peptides and peptidomimetics. The Fmoc group provides a base-labile protection strategy that can be removed under conditions compatible with many peptide synthesis cycles, supporting scalable preparation of peptide fragments without exposing the α-amino group prematurely. The D stereocenter ensures that downstream peptide products retain the intended configuration, which is critical for producing diastereomerically defined intermediates used in SAR studies and stereochemical method development. The guanidinium side chain, while strongly basic, can be accommodated in synthetic planning for either retention during peptide assembly or selective transformation in later steps to access alternative functional guanidine analogs.

5. SAR Studies

N-α-Fmoc-D-Arginine is employed in structure-activity relationship studies that require systematic variation of stereochemistry and side-chain presentation within peptide scaffolds. The D-arginine configuration enables generation of epimeric or stereochemically constrained analogs that can reveal how α-stereochemistry impacts binding affinity, proteolytic resistance, and conformational preferences. The Fmoc-protected α-amino group supports consistent peptide coupling across analog series, improving comparability of structural changes introduced at the arginine position. The guanidinium group provides a strong electrostatic and hydrogen-bonding motif that can be preserved to maintain charge-driven recognition while other regions of the scaffold are varied, supporting rational design of peptide analogs and peptidomimetic fragments.

6. Pharmaceutical Manufacturing

N-α-Fmoc-D-Arginine is applicable to pharmaceutical manufacturing and fine chemical production of D-arginine-containing peptide intermediates used in process development and controlled synthesis of peptide-based materials. The Fmoc protection strategy aligns with industrially established peptide synthesis logic, where orthogonal protection and reliable N-terminal deprotection cycles support reproducible fragment assembly. The presence of a stereodefined D-α-carbon and the guanidinium side chain assists in producing consistent, charge-character-defined peptide intermediates for downstream formulation development and analytical characterization. The compound's role as a protected amino acid building block supports scalable preparation of sequence-defined intermediates that can be further processed into peptide analogs, reference standards, or manufacturing feedstocks for applied chemical production.

1. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

2. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

3. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs

4. Olfactory receptor based piezoelectric biosensors for detection of alcohols related to food safety applications

5. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells